ALK (anaplastic lymphoma kinase, CD246)-specific CARs: new immunotherapeutic agents for the treatment of pediatric solid tumors
Rimas J Orentas,Paola Lopomo,William Babbitt…Volume:
1
Language:
english
Journal:
Journal for Immunotherapy of Cancer
DOI:
10.1186/2051-1426-1-S1-P27
Date:
November, 2013
File:
PDF, 73 KB
english, 2013